المؤلفون: Quinlan C., Wardrop L., West K.H., White S.M., Wilkins E., Mallett A.J., Jayasinghe K., Stark Z., Kerr P.G., Gaff C., Martyn M., Whitlam J., Creighton B., Donaldson E., Hunter M., Jarmolowicz A., Johnstone L., Krzesinski E., Lunke S., Lynch E., Nicholls K., Patel C., Prawer Y., Ryan J., See E.J., Talbot A., Trainer A., Tytherleigh R., Valente G., Wallis M.

مصطلحات الفهرس: human, human tissue, infant, kidney biopsy, controlled study, kidney disease/dt [Drug Therapy], major clinical study, male, molecular diagnosis, kidney disease/di [Diagnosis], diagnostic value, disease association, disease surveillance, family study, female, health care facility, renin inhibitor/dt [Drug Therapy], renin inhibitor/pv [Special Situation for Pharmacovigilance], adolescent, adult, article, Australia, child, chronic kidney failure, clinical trial, cohort analysis, monogenic disorder/di [Diagnosis], monogenic disorder/dt [Drug Therapy], multidisciplinary team, prediction, prospective study, tertiary care center, whole exome sequencing, angiotensin antagonist/dt [Drug Therapy], angiotensin antagonist/pv [Special Situation for Pharmacovigilance], cyclosporine/dt [Drug Therapy], cyclosporine/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26525
Genetics in Medicine
Click here for full text options
LibKey Link

المؤلفون: Fleming S., Loh J.B.E., Walker P., Avery S., Patil S., Spencer A., Wei A.

مصطلحات الفهرس: female, gene mutation, graft recipient, haploidentical transplantation, human, induction chemotherapy, letter, leukemia relapse, leukemia remission, male, minimal residual disease, monosomy 7, multiple cycle treatment, myeloblast, myelodysplastic syndrome, pancytopenia/dt [Drug Therapy], priority journal, real time reverse transcription polymerase chain reaction, renal replacement therapy-dependent renal disease, sibling donor, transplantation conditioning, unrelated donor, cyclosporine/dt [Drug Therapy], cyclosporine/tm [Unexpected Outcome of Drug Treatment], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], DNA methyltransferase 3A/ec [Endogenous Compound], etoposide/dt [Drug Therapy], fludarabine, idarubicin/dt [Drug Therapy], idarubicin/pv [Special Situation for Pharmacovigilance], melphalan, nucleophosmin/ec [Endogenous Compound], thiotepa, thymocyte antibody/dt [Drug Therapy], venetoclax/dt [Drug Therapy], consolidation chemotherapy, CD135 antigen/ec [Endogenous Compound], CD33 antigen/ec [Endogenous Compound], cyclophosphamide, acute myeloid leukemia/dt [Drug Therapy], adult, aged, allogeneic stem cell transplantation, aplastic anemia/dt [Drug Therapy], bone marrow biopsy, cancer chemotherapy, cancer patient, case report, chimera, clinical article, continuous infusion, DNA methylation, dysplasia, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27242
Leukemia and Lymphoma
Click here for full text options
LibKey Link

المؤلفون: Jesudason S., Tang J., Gulyani A., Hewawasam E., McDonald S., Clayton P., Webster A.C., Kanellis J.

مصطلحات الفهرس: kidney pancreas transplantation, live birth, major clinical study, maternal age, non insulin dependent diabetes mellitus, pancreas function, peripheral vascular disease, pregnancy outcome, pregnant woman, primigravida, priority journal, creatinine/ec [Endogenous Compound], cyclosporine/dt [Drug Therapy], mycophenolate mofetil/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], mammalian target of rapamycin inhibitor/dt [Drug Therapy], adult, article, Australia and New Zealand, clinical decision making, cohort analysis, comparative study, controlled study, coronary artery disease, creatinine blood level, disease registry, end stage renal disease/dt [Drug Therapy], end stage renal disease/su [Surgery], female, fetus outcome, graft recipient, human, immunosuppressive treatment, insulin dependent diabetes mellitus, kidney function, kidney graft, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26975
Clinical Transplantation
Click here for full text options
LibKey Link

المؤلفون: Quinlan C., Wardrop L., West K.H., White S.M., Wilkins E., Mallett A.J., Jayasinghe K., Stark Z., Kerr P.G., Gaff C., Martyn M., Whitlam J., Creighton B., Donaldson E., Hunter M., Jarmolowicz A., Johnstone L., Krzesinski E., Lunke S., Lynch E., Nicholls K., Patel C., Prawer Y., Ryan J., See E.J., Talbot A., Trainer A., Tytherleigh R., Valente G., Wallis M.

مصطلحات الفهرس: human, human tissue, infant, kidney biopsy, controlled study, kidney disease/dt [Drug Therapy], major clinical study, male, molecular diagnosis, kidney disease/di [Diagnosis], diagnostic value, disease association, disease surveillance, family study, female, health care facility, renin inhibitor/dt [Drug Therapy], renin inhibitor/pv [Special Situation for Pharmacovigilance], adolescent, adult, article, Australia, child, chronic kidney failure, clinical trial, cohort analysis, monogenic disorder/di [Diagnosis], monogenic disorder/dt [Drug Therapy], multidisciplinary team, prediction, prospective study, tertiary care center, whole exome sequencing, angiotensin antagonist/dt [Drug Therapy], angiotensin antagonist/pv [Special Situation for Pharmacovigilance], cyclosporine/dt [Drug Therapy], cyclosporine/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26525
Genetics in Medicine
LibKey Link

المؤلفون: Fleming S., Loh J.B.E., Walker P., Avery S., Patil S., Spencer A., Wei A.

مصطلحات الفهرس: female, gene mutation, graft recipient, haploidentical transplantation, human, induction chemotherapy, letter, leukemia relapse, leukemia remission, male, minimal residual disease, monosomy 7, multiple cycle treatment, myeloblast, myelodysplastic syndrome, pancytopenia/dt [Drug Therapy], priority journal, real time reverse transcription polymerase chain reaction, renal replacement therapy-dependent renal disease, sibling donor, transplantation conditioning, unrelated donor, cyclosporine/dt [Drug Therapy], cyclosporine/tm [Unexpected Outcome of Drug Treatment], cytarabine/dt [Drug Therapy], cytarabine/pv [Special Situation for Pharmacovigilance], DNA methyltransferase 3A/ec [Endogenous Compound], etoposide/dt [Drug Therapy], fludarabine, idarubicin/dt [Drug Therapy], idarubicin/pv [Special Situation for Pharmacovigilance], melphalan, nucleophosmin/ec [Endogenous Compound], thiotepa, thymocyte antibody/dt [Drug Therapy], venetoclax/dt [Drug Therapy], consolidation chemotherapy, CD135 antigen/ec [Endogenous Compound], CD33 antigen/ec [Endogenous Compound], cyclophosphamide, acute myeloid leukemia/dt [Drug Therapy], adult, aged, allogeneic stem cell transplantation, aplastic anemia/dt [Drug Therapy], bone marrow biopsy, cancer chemotherapy, cancer patient, case report, chimera, clinical article, continuous infusion, DNA methylation, dysplasia, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27242
Leukemia and Lymphoma
LibKey Link

المؤلفون: Jesudason S., Tang J., Gulyani A., Hewawasam E., McDonald S., Clayton P., Webster A.C., Kanellis J.

مصطلحات الفهرس: kidney pancreas transplantation, live birth, major clinical study, maternal age, non insulin dependent diabetes mellitus, pancreas function, peripheral vascular disease, pregnancy outcome, pregnant woman, primigravida, priority journal, creatinine/ec [Endogenous Compound], cyclosporine/dt [Drug Therapy], mycophenolate mofetil/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], mammalian target of rapamycin inhibitor/dt [Drug Therapy], adult, article, Australia and New Zealand, clinical decision making, cohort analysis, comparative study, controlled study, coronary artery disease, creatinine blood level, disease registry, end stage renal disease/dt [Drug Therapy], end stage renal disease/su [Surgery], female, fetus outcome, graft recipient, human, immunosuppressive treatment, insulin dependent diabetes mellitus, kidney function, kidney graft, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26975
Clinical Transplantation
LibKey Link

المؤلفون: Chong A.H., Prakash S., Kerkemeyer K.L.S.

مصطلحات الفهرس: letter, medical history, middle aged, nausea/si [Side Effect], repeated drug dose, retreatment, skin defect, skin granuloma/di [Diagnosis], skin granuloma/dr [Drug Resistance], skin granuloma/dt [Drug Therapy], skin infiltrate/di [Diagnosis], sunlight protection, corticosteroid/dt [Drug Therapy], corticosteroid/tp [Topical Drug Administration], corticosteroid/tm [Unexpected Outcome of Drug Treatment], cyclosporine/ae [Adverse Drug Reaction], cyclosporine/dt [Drug Therapy], etretin/ae [Adverse Drug Reaction], etretin/do [Drug Dose], etretin/dt [Drug Therapy], etretin/po [Oral Drug Administration], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/tm [Unexpected Outcome of Drug Treatment], methotrexate/dt [Drug Therapy], methotrexate/tm [Unexpected Outcome of Drug Treatment], sunscreen, triamcinolone/dt [Drug Therapy], triamcinolone/il [Intralesional Drug Administration], actinic granuloma/di [Diagnosis], actinic granuloma/dr [Drug Resistance], actinic granuloma/dt [Drug Therapy], female, adult, biopsy, case report, clinical article, dose response, drug substitution, drug withdrawal, dry skin/si [Side Effect], erythema, giant cell, human, human tissue, inflammatory infiltrate, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35478
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

المؤلفون: Proudman S., Ferdowsi N., Hill C., Roddy J., Walker J., Nikpour M., Morrisroe K., Hansen D., Huq M., Stevens W., Sahhar J., Ngian G.-S.

مصطلحات الفهرس: breast cancer, cancer incidence, cancer mortality, cancer patient, cancer risk, cancer survival, cohort analysis, controlled study, disease burden, female, health care cost, health care utilization, hematologic malignancy, human, lung cancer, major clinical study, malignant neoplasm/dt [Drug Therapy], melanoma, proportional hazards model, prospective study, risk factor, standardized incidence ratio, systemic sclerosis/di [Diagnosis], systemic sclerosis/dm [Disease Management], systemic sclerosis/dt [Drug Therapy], treatment outcome, abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], DNA directed RNA polymerase III/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolate mofetil/dt [Drug Therapy], rituximab/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], male, adult, article, Australian, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28980
Arthritis Care and Research
Click here for full text options
LibKey Link

المؤلفون: Antony A., Connelly K., De Silva T., Eades L., Tillett W., Morand E., Ayoub S.

مصطلحات الفهرس: psoriatic arthritis/di [Diagnosis], psoriatic arthritis/dt [Drug Therapy], rheumatic disease, rheumatoid arthritis/di [Diagnosis], rheumatoid arthritis/dt [Drug Therapy], rheumatology, scleroderma/di [Diagnosis], scleroderma/dt [Drug Therapy], social acceptance, spondylarthritis/di [Diagnosis], spondylarthritis/dt [Drug Therapy], systemic lupus erythematosus/di [Diagnosis], systemic lupus erythematosus/dt [Drug Therapy], telehealth, therapeutic misconception, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], Janus kinase inhibitor/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], salazosulfapyridine/dt [Drug Therapy], secukinumab/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ustekinumab/dt [Drug Therapy], infection control, adult, article, controlled study, coronavirus disease 2019/di [Diagnosis], coronavirus disease 2019/dt [Drug Therapy], disease course, disease severity, drug use, female, health survey, human, major clinical study, male, medical information, middle aged, pandemic, patient participation, patient risk, perception, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29085
Arthritis Care and Research
Click here for full text options
LibKey Link

المؤلفون: Chong A.H., Prakash S., Kerkemeyer K.L.S.

مصطلحات الفهرس: letter, medical history, middle aged, nausea/si [Side Effect], repeated drug dose, retreatment, skin defect, skin granuloma/di [Diagnosis], skin granuloma/dr [Drug Resistance], skin granuloma/dt [Drug Therapy], skin infiltrate/di [Diagnosis], sunlight protection, corticosteroid/dt [Drug Therapy], corticosteroid/tp [Topical Drug Administration], corticosteroid/tm [Unexpected Outcome of Drug Treatment], cyclosporine/ae [Adverse Drug Reaction], cyclosporine/dt [Drug Therapy], etretin/ae [Adverse Drug Reaction], etretin/do [Drug Dose], etretin/dt [Drug Therapy], etretin/po [Oral Drug Administration], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/tm [Unexpected Outcome of Drug Treatment], methotrexate/dt [Drug Therapy], methotrexate/tm [Unexpected Outcome of Drug Treatment], sunscreen, triamcinolone/dt [Drug Therapy], triamcinolone/il [Intralesional Drug Administration], actinic granuloma/di [Diagnosis], actinic granuloma/dr [Drug Resistance], actinic granuloma/dt [Drug Therapy], female, adult, biopsy, case report, clinical article, dose response, drug substitution, drug withdrawal, dry skin/si [Side Effect], erythema, giant cell, human, human tissue, inflammatory infiltrate, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35478
Australasian Journal of Dermatology
LibKey Link

المؤلفون: Proudman S., Ferdowsi N., Hill C., Roddy J., Walker J., Nikpour M., Morrisroe K., Hansen D., Huq M., Stevens W., Sahhar J., Ngian G.-S.

مصطلحات الفهرس: breast cancer, cancer incidence, cancer mortality, cancer patient, cancer risk, cancer survival, cohort analysis, controlled study, disease burden, female, health care cost, health care utilization, hematologic malignancy, human, lung cancer, major clinical study, malignant neoplasm/dt [Drug Therapy], melanoma, proportional hazards model, prospective study, risk factor, standardized incidence ratio, systemic sclerosis/di [Diagnosis], systemic sclerosis/dm [Disease Management], systemic sclerosis/dt [Drug Therapy], treatment outcome, abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], DNA directed RNA polymerase III/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolate mofetil/dt [Drug Therapy], rituximab/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], male, adult, article, Australian, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28980
Arthritis Care and Research
LibKey Link

المؤلفون: Antony A., Connelly K., De Silva T., Eades L., Tillett W., Morand E., Ayoub S.

مصطلحات الفهرس: psoriatic arthritis/di [Diagnosis], psoriatic arthritis/dt [Drug Therapy], rheumatic disease, rheumatoid arthritis/di [Diagnosis], rheumatoid arthritis/dt [Drug Therapy], rheumatology, scleroderma/di [Diagnosis], scleroderma/dt [Drug Therapy], social acceptance, spondylarthritis/di [Diagnosis], spondylarthritis/dt [Drug Therapy], systemic lupus erythematosus/di [Diagnosis], systemic lupus erythematosus/dt [Drug Therapy], telehealth, therapeutic misconception, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], Janus kinase inhibitor/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], salazosulfapyridine/dt [Drug Therapy], secukinumab/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ustekinumab/dt [Drug Therapy], infection control, adult, article, controlled study, coronavirus disease 2019/di [Diagnosis], coronavirus disease 2019/dt [Drug Therapy], disease course, disease severity, drug use, female, health survey, human, major clinical study, male, medical information, middle aged, pandemic, patient participation, patient risk, perception, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29085
Arthritis Care and Research
LibKey Link

المؤلفون: Firkin F., Szer J., Blombery P., McQuilten Z.K., Hiwase D., Cole-Sinclair M.F., Clucas D.B., Fox L.C., Wood E.M., Hong F.S., Gibson J., Bajel A.

مصطلحات الفهرس: aplastic anemia/ep [Epidemiology], aplastic anemia/et [Etiology], aplastic anemia/th [Therapy], blood analysis, blood transfusion, bone marrow examination, clinical feature, disease association, drug efficacy, drug response, drug safety, erythrocyte transfusion, fever/dt [Drug Therapy], fever/si [Side Effect], hematopoietic stem cell transplantation, immunosuppressive treatment, incidence, iron chelation, iron overload/co [Complication], iron overload/dt [Drug Therapy], iron overload/su [Surgery], myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria, pathogenesis, phlebotomy, priority journal, psychosocial care, quality of life, rash/dt [Drug Therapy], rash/si [Side Effect], relapse, review, thrombocytopenia/dt [Drug Therapy], thrombocytopenia/si [Side Effect], cyclosporine/cb [Drug Combination], cyclosporine/dt [Drug Therapy], deferasirox/dt [Drug Therapy], prednisolone/dt [Drug Therapy], thymocyte antibody/ae [Adverse Drug Reaction], thymocyte antibody/cb [Drug Combination], thymocyte antibody/dt [Drug Therapy], human, acute myeloid leukemia, aplastic anemia/di [Diagnosis], aplastic anemia/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36226
Internal Medicine Journal
Click here for full text options
LibKey Link

المؤلفون: Bruno D.L., Slater H.R., Whitlam J.B., Ling L., Skene A., Kanellis J., Ierino F.L., Power D.A.

مصطلحات الفهرس: renal graft dysfunction/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], DNA/ec [Endogenous Compound], mammalian target of rapamycin/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], OKT 3/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], adult, antibody mediated rejection, antibody specificity, article, blood sampling, cohort analysis, comparative study, controlled study, creatinine blood level, cross-sectional study, diagnostic test accuracy study, droplet digital polymerase chain reaction, female, genotype, histopathology, human, human tissue, immunosuppressive treatment, kidney allograft, major clinical study, priority journal, prospective study, proteinuria, renal graft dysfunction/di [Diagnosis], male, renal graft dysfunction/pc [Prevention], sensitivity and specificity, azathioprine/dt [Drug Therapy], basiliximab/dt [Drug Therapy], creatinine/ec [Endogenous Compound], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35734
American Journal of Transplantation
Click here for full text options
LibKey Link

المؤلفون: Bruno D.L., Slater H.R., Whitlam J.B., Ling L., Skene A., Kanellis J., Ierino F.L., Power D.A.

مصطلحات الفهرس: renal graft dysfunction/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], DNA/ec [Endogenous Compound], mammalian target of rapamycin/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], OKT 3/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], adult, antibody mediated rejection, antibody specificity, article, blood sampling, cohort analysis, comparative study, controlled study, creatinine blood level, cross-sectional study, diagnostic test accuracy study, droplet digital polymerase chain reaction, female, genotype, histopathology, human, human tissue, immunosuppressive treatment, kidney allograft, major clinical study, priority journal, prospective study, proteinuria, renal graft dysfunction/di [Diagnosis], male, renal graft dysfunction/pc [Prevention], sensitivity and specificity, azathioprine/dt [Drug Therapy], basiliximab/dt [Drug Therapy], creatinine/ec [Endogenous Compound], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35734
American Journal of Transplantation
LibKey Link

المؤلفون: Firkin F., Szer J., Blombery P., McQuilten Z.K., Hiwase D., Cole-Sinclair M.F., Clucas D.B., Fox L.C., Wood E.M., Hong F.S., Gibson J., Bajel A.

مصطلحات الفهرس: aplastic anemia/ep [Epidemiology], aplastic anemia/et [Etiology], aplastic anemia/th [Therapy], blood analysis, blood transfusion, bone marrow examination, clinical feature, disease association, drug efficacy, drug response, drug safety, erythrocyte transfusion, fever/dt [Drug Therapy], fever/si [Side Effect], hematopoietic stem cell transplantation, immunosuppressive treatment, incidence, iron chelation, iron overload/co [Complication], iron overload/dt [Drug Therapy], iron overload/su [Surgery], myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria, pathogenesis, phlebotomy, priority journal, psychosocial care, quality of life, rash/dt [Drug Therapy], rash/si [Side Effect], relapse, review, thrombocytopenia/dt [Drug Therapy], thrombocytopenia/si [Side Effect], cyclosporine/cb [Drug Combination], cyclosporine/dt [Drug Therapy], deferasirox/dt [Drug Therapy], prednisolone/dt [Drug Therapy], thymocyte antibody/ae [Adverse Drug Reaction], thymocyte antibody/cb [Drug Combination], thymocyte antibody/dt [Drug Therapy], human, acute myeloid leukemia, aplastic anemia/di [Diagnosis], aplastic anemia/dt [Drug Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36226
Internal Medicine Journal
LibKey Link

المؤلفون: Burgner D., Phuong L.K., Gowdie P., Curtis N., Akikusa J.

مصطلحات الفهرس: human, methodology, mucocutaneous lymph node syndrome/dr [Drug Resistance], mucocutaneous lymph node syndrome/dt [Drug Therapy], mucocutaneous lymph node syndrome/th [Therapy], plasma exchange, practice guideline, priority journal, treatment planning, acetylsalicylic acid/dt [Drug Therapy], anakinra/dt [Drug Therapy], biological product/dt [Drug Therapy], chlorpheniramine/dt [Drug Therapy], corticosteroid/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], cytotoxic agent/dt [Drug Therapy], diphenhydramine/dt [Drug Therapy], heparin/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], infliximab/dt [Drug Therapy], methotrexate/dt [Drug Therapy], methylprednisolone/dt [Drug Therapy], paracetamol/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], steroid/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ulinastatin/dt [Drug Therapy], review, combination chemotherapy, disease classification, drug treatment failure, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38499
Pediatric Drugs
Click here for full text options
LibKey Link

المؤلفون: Pagliuca A., de Lavallade H., Potter V., Kenyon M., Mufti G., Marsh J., Tedjaseputra A., McLornan D., McCormick J., Raj K.

مصطلحات الفهرس: Coombs test, creatinine blood level, human, human cell, human tissue, hypoalbuminemia, kidney biopsy, kidney function, letter, limb weakness, lumbar puncture, male, membranous glomerulonephritis/di [Diagnosis], membranous glomerulonephritis/dt [Drug Therapy], middle aged, myelitis/di [Diagnosis], myelodysplastic syndrome/th [Therapy], receptor antibody/ec [Endogenous Compound], rituximab/dt [Drug Therapy], thymocyte antibody, unclassified drug, phospholipase A2 receptor antibody/ec [Endogenous Compound], peripheral edema, priority journal, thrombocytopenia/di [Diagnosis], transplantation conditioning, albumin/ec [Endogenous Compound], busulfan, creatinine/ec [Endogenous Compound], cyclosporine/dt [Drug Therapy], fludarabine, hemoglobin/ec [Endogenous Compound], phospholipase A2 receptor/ec [Endogenous Compound], acute kidney failure, adult, albumin blood level, allogeneic stem cell transplantation, autoimmune disease/di [Diagnosis], autoimmune disease/dt [Drug Therapy], autoimmune hemolytic anemia/di [Diagnosis], body weight gain, case report, clinical article, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37503
Internal Medicine Journal
Click here for full text options
LibKey Link

المؤلفون: Siow W., Skoien R., Mitchell J., Zekry A., George J., MacQuillan G., Wigg A., Stuart K., McCaughan G., Sievert W., Lim R., Strasser S., Nicoll A., Gazzola A., Roberts S.K., Khoo T., Hamarneh Z., Weltman M., Gow P., Janko N., Tse E., Mishra G., Cheng E.-H., Levy M., Cheng W., Sood S.

مصطلحات الفهرس: multiple organ failure/si [Side Effect], nausea/si [Side Effect], necrotizing fasciitis/si [Side Effect], outcome assessment, pancreatitis/si [Side Effect], portal hypertension/si [Side Effect], remission, retrospective study, sepsis/si [Side Effect], sex difference, skin cancer/si [Side Effect], skin toxicity/si [Side Effect], stomatitis/si [Side Effect], tooth abscess/si [Side Effect], treatment duration, treatment indication, treatment outcome, urinary tract infection/si [Side Effect], vomiting/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], azathioprine/ae [Adverse Drug Reaction], azathioprine/cb [Drug Combination], azathioprine/dt [Drug Therapy], budesonide/cb [Drug Combination], budesonide/dt [Drug Therapy], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], immunoglobulin G/ec [Endogenous Compound], mercaptopurine/ae [Adverse Drug Reaction], mercaptopurine/cb [Drug Combination], mercaptopurine/dt [Drug Therapy], mycophenolate mofetil/ae [Adverse Drug Reaction], mycophenolate mofetil/dt [Drug Therapy], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], bone marrow suppression/si [Side Effect], article, aspartate aminotransferase blood level, autoimmune hepatitis/di [Diagnosis], abdominal discomfort/si [Side Effect], abdominal pain/si [Side Effect], adult, age distribution, alanine aminotransferase blood level, anxiety disorder/si [Side Effect], autoimmune hepatitis/dt [Drug Therapy], body weight, arthralgia/si [Side Effect], Child Pugh score, clinical effectiveness, controlled study, cytopenia/si [Side Effect], demography, descriptive research, diarrhea/si [Side Effect], drug eruption/si [Side Effect], drug fatality/si [Side Effect], drug fever/si [Side Effect], drug safety, drug tolerability, drug treatment failure, ethnic difference, female, hair loss/si [Side Effect], human, infection rate, insomnia/si [Side Effect], liver cirrhosis, liver toxicity/si [Side Effect], major clinical study, male, methicillin resistant Staphylococcus aureus infection/si [Side Effect], mood disorder/si [Side Effect], multicenter study, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36973
Clinical Gastroenterology and Hepatology
Click here for full text options
LibKey Link

المؤلفون: Strippoli G.F.M., Masson P., Craig J.C., Tong A., Singh-Grewal D., Flanc R.S., Roberts M.A., Webster A.C., Tunnicliffe D.J., Palmer S.C., Henderson L.

مصطلحات الفهرس: leukopenia/si [Side Effect], low drug dose, lupus erythematosus nephritis/dt [Drug Therapy], lupus erythematosus nephritis/th [Therapy], maintenance therapy, malignant neoplasm/si [Side Effect], menstrual irregularity/si [Side Effect], morning dosage, multiple cycle treatment, nausea/si [Side Effect], ovary insufficiency/si [Side Effect], plasma exchange, priority journal, proteinuria, randomized controlled trial (topic), relapse, remission, review, SLEDAI, systematic review, vomiting/si [Side Effect], abatacept/ae [Adverse Drug Reaction], abatacept/ct [Clinical Trial], abatacept/cb [Drug Combination], abatacept/cm [Drug Comparison], abatacept/dt [Drug Therapy], atacicept/ct [Clinical Trial], atacicept/cb [Drug Combination], atacicept/cm [Drug Comparison], atacicept/dt [Drug Therapy], azathioprine/ae [Adverse Drug Reaction], azathioprine/ct [Clinical Trial], azathioprine/cb [Drug Combination], azathioprine/cm [Drug Comparison], azathioprine/dt [Drug Therapy], azathioprine/po [Oral Drug Administration], calcineurin inhibitor/ae [Adverse Drug Reaction], calcineurin inhibitor/ct [Clinical Trial], calcineurin inhibitor/cb [Drug Combination], calcineurin inhibitor/cm [Drug Comparison], calcineurin inhibitor/dt [Drug Therapy], corticosteroid/ae [Adverse Drug Reaction], corticosteroid/ct [Clinical Trial], corticosteroid/ad [Drug Administration], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], corticosteroid/iv [Intravenous Drug Administration], corticosteroid/po [Oral Drug Administration], cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/ct [Clinical Trial], cyclophosphamide/ad [Drug Administration], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], cyclophosphamide/po [Oral Drug Administration], cyclosporine/ct [Clinical Trial], cyclosporine/cb [Drug Combination], cyclosporine/cm [Drug Comparison], cyclosporine/dt [Drug Therapy], cyclosporine/po [Oral Drug Administration], glucocorticoid/cb [Drug Combination], glucocorticoid/dt [Drug Therapy], glucocorticoid/po [Oral Drug Administration], immunoglobulin/ct [Clinical Trial], immunoglobulin/cm [Drug Comparison], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], immunosuppressive agent/ct [Clinical Trial], immunosuppressive agent/cb [Drug Combination], immunosuppressive agent/cm [Drug Comparison], immunosuppressive agent/dt [Drug Therapy], immunosuppressive agent/sc [Subcutaneous Drug Administration], laquinimod/ct [Clinical Trial], laquinimod/cb [Drug Combination], laquinimod/cm [Drug Comparison], laquinimod/dt [Drug Therapy], laquinimod/po [Oral Drug Administration], leflunomide/ct [Clinical Trial], leflunomide/cb [Drug Combination], leflunomide/cm [Drug Comparison], leflunomide/dt [Drug Therapy], leflunomide/po [Oral Drug Administration], methylprednisolone/ct [Clinical Trial], methylprednisolone/cb [Drug Combination], methylprednisolone/cm [Drug Comparison], methylprednisolone/dt [Drug Therapy], methylprednisolone/iv [Intravenous Drug Administration], misoprostol/ct [Clinical Trial], misoprostol/cb [Drug Combination], misoprostol/cm [Drug Comparison], misoprostol/dt [Drug Therapy], misoprostol/po [Oral Drug Administration], mycophenolate mofetil/ae [Adverse Drug Reaction], mycophenolate mofetil/ct [Clinical Trial], mycophenolate mofetil/cb [Drug Combination], mycophenolate mofetil/cm [Drug Comparison], mycophenolate mofetil/dt [Drug Therapy], mycophenolate mofetil/po [Oral Drug Administration], mycophenolic acid/ct [Clinical Trial], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], ocrelizumab/ae [Adverse Drug Reaction], ocrelizumab/ct [Clinical Trial], ocrelizumab/cb [Drug Combination], ocrelizumab/cm [Drug Comparison], ocrelizumab/dt [Drug Therapy], placebo, prednisolone/ct [Clinical Trial], prednisolone/cb [Drug Combination], prednisolone/cm [Drug Comparison], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], prednisone/ae [Adverse Drug Reaction], prednisone/ct [Clinical Trial], prednisone/cb [Drug Combination], prednisone/cm [Drug Comparison], prednisone/dt [Drug Therapy], prednisone/po [Oral Drug Administration], rituximab/ae [Adverse Drug Reaction], rituximab/ct [Clinical Trial], rituximab/cb [Drug Combination], rituximab/cm [Drug Comparison], rituximab/dt [Drug Therapy], sirukumab/ae [Adverse Drug Reaction], sirukumab/ct [Clinical Trial], sirukumab/cb [Drug Combination], sirukumab/cm [Drug Comparison], sirukumab/dt [Drug Therapy], sirukumab/iv [Intravenous Drug Administration], tacrolimus/ae [Adverse Drug Reaction], tacrolimus/ct [Clinical Trial], tacrolimus/cb [Drug Combination], tacrolimus/cm [Drug Comparison], tacrolimus/dt [Drug Therapy], tacrolimus/po [Oral Drug Administration], unclassified drug, voclosporin/ct [Clinical Trial], voclosporin/cb [Drug Combination], voclosporin/cm [Drug Comparison], voclosporin/dt [Drug Therapy], AMG 811/ct [Clinical Trial], AMG 811/cm [Drug Comparison], AMG 811/sc [Subcutaneous Drug Administration], AMG 811/dt [Drug Therapy], all cause mortality, alopecia/si [Side Effect], biological therapy, bladder disease/si [Side Effect], bone disease/si [Side Effect], creatinine blood level, creatinine clearance, diarrhea/si [Side Effect], disease activity, dosage schedule comparison, drug dose comparison, drug dose increase, drug dose reduction, drug dose titration, drug megadose, drug withdrawal, end stage renal disease, gastrointestinal symptom/si [Side Effect], herpes zoster/si [Side Effect], human, immunoadsorption, immunosuppressive treatment, infection/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37602
Cochrane Database of Systematic Reviews
Click here for full text options
LibKey Link